Table 1.
Clinical characteristics of patients in Biofeedback groups and FMT combination group.
| Biofeedback group (n = 40) | FMT combination group(n = 45) | p-Value | |
|---|---|---|---|
| Age | 45.5 ± 7.6 | 46.1 ± 7.1 | >0.05 |
| Sex (Male/Female) | 14/26 | 14/31 | >0.05 |
| BMI (kg/m2) | 21.5 ± 3.4 | 21.6 ± 2.7 | >0.05 |
| Underlying disease | |||
| Diabetes | 6 (15%) | 8 (17.8%) | >0.05 |
| Cardiovascular disease | 5 (12.5%) | 7 (15.6%) | >0.05 |
| Parkinson's disease | 2 (5%) | 1 (2.2%) | >0.05 |
| Concomitant laxative | |||
| Senna extract | 19 (47.5%) | 23 (51.1%) | >0.05 |
| Polyethylene glycol-electrolyte powder | 29 (72.5%) | 19 (42.2%) | 0.008 |
| Bisacodyl | 11 (27.5%) | 21 (46.7%) | >0.05 |
| Aole paidu capsule | 14 (40%) | 11 (24.4%) | >0.05 |
| Phenolphthalein tablets | 15 (37.5%) | 5 (11.1%) | 0.005 |
| Rhubarb | 6 (15%) | 10 (22.2%) | >0.05 |